Clinical Trials Directory

Trials / Completed

CompletedNCT07225166

A Clinical Investigation Into the Association of an Impaired Skin Barrier and Infant and Toddler Sensitive Skin

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Kenvue Brands LLC · Industry
Sex
All
Age
3 Months – 36 Months
Healthy volunteers
Accepted

Summary

This is a Single center, evaluator-blinded clinical trial that intends to • Evaluate differences in TEWL measurements between parent-reported sensitive skin subjects and healthy subjects (subjects without sensitive skin) • Evaluate differences in skin capacitance between parent-reported sensitive skin subjects and healthy subjects (subjects without sensitive skin). A sufficient number of subjects pairs (comprised of a parent subject and a child subject) will be enrolled to complete the study with at least 60 subject pairs (30 subject pairs per group).

Conditions

Interventions

TypeNameDescription
OTHERExpert Clinical GradingThe expert grader will separately assess each child subject's face and body (right and left volar forearms combined, right and left leg combined, torso) for each of the parameters below according to the following 4-point scales (half points are allowed): \- Visual Dryness, Tactile Surface Roughness, Erythema.
OTHERInstrumental MeasurementsThe following procedures will be conducted on the child subject: * Corneometer measurements * Tewameter measurements * Skin pH Meter measurements
OTHERParental QuestionnairesThe following questionnaires will be given to the parent subject to answer: * Questionnaire: Reaction to Environmental, Chemical, and Mechanical Stimuli * Questionnaire: Medical/Family History Questionnaire * Questionnaire: Bathing and Skincare Routines
OTHERBiomarker MeasurementsThe following procedures will be conducted on the child subject: * D-Squame skin sampling (for corneocyte visualization and lipid analysis) * Microbiome sampling * D-Squame skin sampling (for inflammatory proteins)

Timeline

Start date
2025-10-01
Primary completion
2025-11-05
Completion
2025-11-05
First posted
2025-11-05
Last updated
2025-11-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07225166. Inclusion in this directory is not an endorsement.